HCW Biologics Inc.
HCWB
$2.46
-$0.05-1.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 741.30K | 1.23M | 1.95M | 1.10M | 2.44M |
| Total Receivables | 18.50K | 74.80K | 32.20K | 30.70K | 21.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 282.50K | 297.80K | 222.20K | 210.70K | 295.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 97.70K | 119.80K | 77.60K | 250.30K | 141.00K |
| Total Current Assets | 1.14M | 1.72M | 2.28M | 1.59M | 2.90M |
|
|
|||||
| Total Current Assets | 1.14M | 1.72M | 2.28M | 1.59M | 2.90M |
| Net Property, Plant & Equipment | 20.75M | 20.77M | 20.88M | 22.50M | 22.64M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 28.50K | 28.50K | 28.50K | 28.50K | 28.50K |
| Total Assets | 26.77M | 27.34M | 24.52M | 25.45M | 28.91M |
|
|
|||||
| Total Accounts Payable | 10.61M | 11.79M | 13.14M | 18.97M | 19.35M |
| Total Accrued Expenses | 1.13M | 1.13M | 1.10M | 1.08M | 1.07M |
| Short-term Debt | 6.56M | 6.58M | 6.81M | 6.81M | 6.42M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 348.30K | 470.00K | 10.10K | -- | -- |
| Total Other Current Liabilities | 348.30K | 470.00K | 10.10K | -- | -- |
| Total Current Liabilities | 18.65M | 19.96M | 21.06M | 26.86M | 26.85M |
|
|
|||||
| Total Current Liabilities | 18.65M | 19.96M | 21.06M | 26.86M | 26.85M |
| Long-Term Debt | -- | -- | -- | -- | 367.20K |
| Short-term Debt | 6.56M | 6.58M | 6.81M | 6.81M | 6.42M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 692.50K | 1.62M | 692.50K | 692.50K | 1.75M |
| Total Liabilities | 19.34M | 21.58M | 21.76M | 27.55M | 28.96M |
|
|
|||||
| Common Stock & APIC | 117.69M | 110.81M | 111.28M | 107.13M | 104.63M |
| Retained Earnings | -110.26M | -105.04M | -108.52M | -109.24M | -104.68M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 7.43M | 5.76M | 2.76M | -2.11M | -52.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.43M | 5.76M | 2.76M | -2.11M | -52.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.43M | 5.76M | 2.76M | -2.11M | -52.00K |
|
|
|||||